UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

In-situ strength tests of coarse, cohesionless debris on scree slopes

Engineering geology, 1995-06, Vol.39 (3), p.137-146

Blijenberg, H.M.

1995

Volltextzugriff (PDF)

INVESTIGATION OF INFILTRATION CHARACTERISTICS AND DEBRIS FLOW INITIATION CONDITIONS IN DEBRIS FLOW SOURCE AREAS USING A RAINFALL SIMULATOR

Hydrological processes, 1996-11, Vol.10 (11), p.1527-1543

1996

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

European urology, 2013-10, Vol.64 (4), p.530-539

2013

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides

Beneficial microbes, 2021-02, Vol.12 (1), p.69-84

2021

Volltextzugriff (PDF)

Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner

PLoS pathogens, 2020-04, Vol.16 (4), p.e1008426

2020

Volltextzugriff (PDF)

The value of (−7, −5)pro‐prostate‐specific antigen and human kallikrein‐2 as serum markers for grading prostate cancer

BJU international, 2004-04, Vol.93 (6), p.720-724

2004

Volltextzugriff (PDF)

Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval

The journal of clinical endocrinology and metabolism, 2004-09, Vol.89 (9), p.4391-4396

2004

Volltextzugriff (PDF)

PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS

The Journal of urology, 2004-06, Vol.171 (6), p.2245-2249

2004

Volltextzugriff (PDF)

Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer

BJU international, 2001-10, Vol.88 (6), p.545-550

2001

Volltextzugriff (PDF)

Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir

Journal of acquired immune deficiency syndromes (1999), 2003-02, Vol.32 (2), p.135-142

2003

Volltextzugriff (PDF)

Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features

European urology, 2002-08, Vol.42 (2), p.154-158

2002

Volltextzugriff (PDF)

Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

International journal of cancer, 2002-01, Vol.97 (2), p.237-244

2002

Volltextzugriff (PDF)

What is an acceptable false negative rate in the detection of prostate cancer?

Translational andrology and urology, 2018-02, Vol.7 (1), p.54-60

2018

Volltextzugriff (PDF)

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

JNCI : Journal of the National Cancer Institute, 2005-05, Vol.97 (9), p.696-696

2005

Volltextzugriff (PDF)

Comparison of Two Assays for Human Kallikrein 2

Clinical chemistry (Baltimore, Md.), 2003-02, Vol.49 (2), p.243-247

2003

Volltextzugriff (PDF)

Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

European randomized study of screening for prostate cancer—The Rotterdam pilot studies

International journal of cancer, 1996-01, Vol.65 (2), p.145-151

1996

Volltextzugriff (PDF)

Rationale for randomised trials of prostate cancer screening

European Journal of Cancer, 1999-02, Vol.35 (2), p.262-271

Alexander, F. E.

1999

Volltextzugriff (PDF)

Rapid microwave-stimulated fixation of entire prostatectomy specimens

The Journal of pathology, 1997-11, Vol.183 (3), p.369-375

1997

Volltextzugriff (PDF)

Analytical issues on prostate-specific antigen in relation to prostate cancer screening

Clinical biochemistry, 1998-11, Vol.31 (8), p.633-639

1998

Volltextzugriff (PDF)

Improvements in creatinine methodology: a critical assessment

European journal of clinical chemistry and clinical biochemistry, 1994-07, Vol.32 (7), p.529

1994

Volltextzugriff (PDF)

Improvements in Creatinine Methodology: A Critical Assessment

Clinical chemistry and laboratory medicine, 1994, Vol.32 (7), p.529-538

1994

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

In-situ strength tests of coarse, cohesionless debris on scree slopes

INVESTIGATION OF INFILTRATION CHARACTERISTICS AND DEBRIS FLOW INITIATION CONDITIONS IN DEBRIS FLOW SOURCE AREAS USING A RAINFALL SIMULATOR

Screening and Prostate-Cancer Mortality in a Randomized European Study

Screening for Prostate Cancer: Results of the Rotterdam Section of the European Randomized Study of Screening for Prostate Cancer

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Prostate-Cancer Mortality at 11 Years of Follow-up

Cross-feeding between Bifidobacterium infantis and Anaerostipes caccae on lactose and human milk oligosaccharides

Killer cell proteases can target viral immediate-early proteins to control human cytomegalovirus infection in a noncytotoxic manner

The value of (−7, −5)pro‐prostate‐specific antigen and human kallikrein‐2 as serum markers for grading prostate cancer

Circulating Free Insulin-Like Growth Factor (IGF)-I , Total IGF-I, and IGF Binding Protein-3 Levels Do Not Predict the Future Risk to Develop Prostate Cancer: Results of a Case-Control Study Involving 201 Patients within a Population-Based Screening with a 4-Year Interval

PROSTATE CANCER DETECTION IN THE PROSTATE SPECIFIC ANTIGEN RANGE OF 2.0 TO 3.9 NG/ML: VALUE OF PERCENT FREE PROSTATE SPECIFIC ANTIGEN ON TUMOR DETECTION AND TUMOR AGGRESSIVENESS

Discordant performance of assays for free and total prostate‐specific antigen in relation to the early detection of prostate cancer

Persistent leukocyturia and loss of renal function in a prospectively monitored cohort of HIV-infected patients treated with indinavir

Different PSA Assays Lead to Detection of Prostate Cancers with Identical Histological Features

Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

What is an acceptable false negative rate in the detection of prostate cancer?

Rotterdam Randomized Pilot Studies of Screening for Prostate Cancer—An Overview After 10 Years

Comparison of Two Assays for Human Kallikrein 2

Prostate Cancer Mortality at 11 years of Follow-up in the ERSPC

European randomized study of screening for prostate cancer—The Rotterdam pilot studies

Rationale for randomised trials of prostate cancer screening

Rapid microwave-stimulated fixation of entire prostatectomy specimens

Analytical issues on prostate-specific antigen in relation to prostate cancer screening

Improvements in creatinine methodology: a critical assessment

Improvements in Creatinine Methodology: A Critical Assessment

Suchergebnisse filtern